CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patientâs EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patientâs EEG data.
äŒæ¥ã³ãŒãCBLL
äŒç€ŸåCeribell Inc
äžå Žæ¥Oct 11, 2024
æé«çµå¶è²¬ä»»è
ãCEOãChao (Xingjuan)
åŸæ¥å¡æ°281
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Oct 11
æ¬ç€Ÿæåšå°360 N. Pastoria Avenue
éœåžSUNNYVALE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·94085
é»è©±çªå·18004360826
ãŠã§ããµã€ãhttps://ceribell.com/
äŒæ¥ã³ãŒãCBLL
äžå Žæ¥Oct 11, 2024
æé«çµå¶è²¬ä»»è
ãCEOãChao (Xingjuan)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã